Infectio (Aug 2021)
Tigeciclina intraventricular como tratamiento de ventriculitis por Chryseobacterium indologenes multirresistente. A propósito de un caso pediátrico
Abstract
Ventriculitis due to Chryseobacterium indologenes can be a major therapeutic challenge, especially when the germ acquires intra-treatment resistance to common antimicrobials. Intraventricular tigecycline could be an excellent option in these cases. We present a schoolgirl`s case who received successfully intraventricular treatment with tigecycline.
Keywords